Markus Meyer

16.8k total citations · 4 hit papers
206 papers, 12.8k citations indexed

About

Markus Meyer is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Markus Meyer has authored 206 papers receiving a total of 12.8k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Cardiology and Cardiovascular Medicine, 69 papers in Molecular Biology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Markus Meyer's work include Cardiovascular Function and Risk Factors (35 papers), Cardiac electrophysiology and arrhythmias (32 papers) and Heart Failure Treatment and Management (31 papers). Markus Meyer is often cited by papers focused on Cardiovascular Function and Risk Factors (35 papers), Cardiac electrophysiology and arrhythmias (32 papers) and Heart Failure Treatment and Management (31 papers). Markus Meyer collaborates with scholars based in United States, Germany and Switzerland. Markus Meyer's co-authors include Patrick A. Baeuerle, Ralf Schreck, Osnat Bartok, Sebastián Kadener, Nikolaus Rajewsky, Mor Hanan, Reut Ashwal-Fluss, Nagarjuna Reddy Pamudurti, Andranik Ivanov and Sebastian Memczak and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Markus Meyer

198 papers receiving 12.5k citations

Hit Papers

circRNA Biogenesis Competes wi... 1993 2026 2004 2015 2014 1993 1994 2015 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. circRNA Biogenesis Competes with Pre-mRNA Splicing
    2014 2.4k citations Markus Meyer et al. profile →
  2. H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor.
    1993 1.2k citations Markus Meyer et al. profile →
  3. Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium.
    1994 609 citations Markus Meyer et al. profile →
  4. Myocardial Stiffness in Patients With Heart Failure and a Preserved Ejection Fraction
    2015 499 citations Michael R. Zile, Bradley M. Palmer et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Meyer United States 49 7.3k 4.3k 2.7k 843 778 206 12.8k
Chen Chen China 61 7.8k 1.1× 1.9k 0.4× 4.0k 1.5× 941 1.1× 896 1.2× 501 14.9k
Fang Liu China 60 8.6k 1.2× 1.4k 0.3× 3.4k 1.3× 636 0.8× 720 0.9× 386 12.9k
Yan Chen China 65 8.4k 1.2× 2.3k 0.5× 1.5k 0.5× 1.7k 2.0× 1.0k 1.3× 416 13.9k
Matteo Antonio Russo Italy 48 3.7k 0.5× 2.4k 0.6× 1.1k 0.4× 1.7k 2.0× 562 0.7× 211 8.8k
Kenichi Yoshida Japan 51 4.2k 0.6× 1.3k 0.3× 1.1k 0.4× 766 0.9× 767 1.0× 366 8.8k
Mohit Jain United States 46 5.5k 0.8× 1.4k 0.3× 1.3k 0.5× 1.1k 1.4× 1.3k 1.6× 149 8.5k
Xiaoyan Liu China 53 7.3k 1.0× 1.1k 0.3× 1.8k 0.7× 1.6k 1.9× 1.1k 1.4× 691 14.3k
Douglas B. Sawyer United States 58 5.7k 0.8× 6.2k 1.5× 626 0.2× 1.5k 1.8× 1.4k 1.8× 198 12.7k
Babette B. Weksler United States 72 4.4k 0.6× 2.0k 0.5× 1.3k 0.5× 2.0k 2.4× 1.5k 1.9× 214 15.5k
Philip A. Marsden Canada 62 4.8k 0.7× 2.6k 0.6× 1.7k 0.6× 5.1k 6.1× 937 1.2× 151 12.7k

Countries citing papers authored by Markus Meyer

Since Specialization
Citations

This map shows the geographic impact of Markus Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Meyer more than expected).

Fields of papers citing papers by Markus Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Meyer. The network helps show where Markus Meyer may publish in the future.

Co-authorship network of co-authors of Markus Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Meyer. A scholar is included among the top collaborators of Markus Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Meyer. Markus Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Habel, Nicole, Margaret Infeld, Daniel L. Lustgarten, & Markus Meyer. (2024). Atrial fibrillation and heart failure with preserved ejection fraction “twindemic”—Shared root causes and treatment targets. Heart Rhythm. 22(5). 1188–1196. 2 indexed citations
2.
Habel, Nicole, Margaret Infeld, Stephen Foley, et al.. (2024). PO-04-041 PHYSIOLOGIC ACCELERATED PACING AS A TREATMENT FOR HEART FAILURE WITH PRESERVED EJECTION FRACTION. Heart Rhythm. 21(5). S469–S470. 1 indexed citations
3.
4.
Arnold, Suzanne V., Daniel N. Silverman, Kensey Gosch, et al.. (2023). Beta-Blocker Use and Heart Failure Outcomes in Mildly Reduced and Preserved Ejection Fraction. JACC Heart Failure. 11(8). 893–900. 49 indexed citations
5.
Habel, Nicole, Jeanne du Fay de Lavallaz, Margaret Infeld, et al.. (2023). Lower heart rates and beta-blockers are associated with new-onset atrial fibrillation. International Journal of Cardiology Cardiovascular Risk and Prevention. 17. 200182–200182. 12 indexed citations
6.
Espriella, Rafael de la, Margaret Infeld, Patricia Palau, et al.. (2023). Effect of Paced Heart Rate on Quality of Life and Natriuretic Peptides for Stage B or C Heart Failure with Preserved Ejection Fraction: A Secondary Analysis of the myPACE Trial. European Journal of Heart Failure. 26(1). 167–176. 4 indexed citations
7.
Infeld, Margaret, Timothy B. Plante, Nicole Habel, et al.. (2023). Effects of Continuous Accelerated Pacing on Cardiac Structure and Function in Patients With Heart Failure With Preserved Ejection Fraction: Insights From the myPACE Randomized Clinical Trial. Journal of the American Heart Association. 13(1). e032873–e032873. 7 indexed citations
8.
Meyer, Markus, Martin M. LeWinter, & Michael R. Zile. (2021). A Targeted Treatment Opportunity for HFpEF: Taking Advantage of Diastolic Tone. Circulation. 144(16). 1269–1271. 11 indexed citations
9.
Dostmann, Wolfgang R., Joel W. Martin, Michael J. Previs, et al.. (2021). SERCA2a-phospholamban interaction monitored by an interposed circularly permutated green fluorescent protein. American Journal of Physiology-Heart and Circulatory Physiology. 320(6). H2188–H2200. 3 indexed citations
10.
LeWinter, Martin M., Douglas J. Taatjes, Takamaru Ashikaga, et al.. (2017). Abundance, localization, and functional correlates of the advanced glycation end-product carboxymethyl lysine in human myocardium. Physiological Reports. 5(20). e13462–e13462. 9 indexed citations
11.
Bell, Stephen P., et al.. (2016). Heart rate-induced modifications of concentric left ventricular hypertrophy: exploration of a novel therapeutic concept. American Journal of Physiology-Heart and Circulatory Physiology. 311(4). H1031–H1039. 22 indexed citations
12.
Meyer, Markus, Stephen P. Bell, Zengyi Chen, et al.. (2013). High dose intracoronary N-acetylcysteine in a porcine model of ST-elevation myocardial infarction. Journal of Thrombosis and Thrombolysis. 36(4). 433–441. 6 indexed citations
13.
Mitrović, Veselin, Adrian F. Hernandez, Markus Meyer, & Mihai Gheorghiade. (2009). Role of guanylate cyclase modulators in decompensated heart failure. Heart Failure Reviews. 14(4). 309–319. 35 indexed citations
14.
Döhler, Klaus D. & Markus Meyer. (2008). Vasopressin analogues in the treatment of hepatorenal syndrome and gastrointestinal haemorrhage. Best Practice & Research Clinical Anaesthesiology. 22(2). 335–350. 13 indexed citations
15.
Gretz, N., R. Schmidt, Brigitte Lelongt, et al.. (2006). Plasma creatinine determination in mice and rats: An enzymatic method compares favorably with a high-performance liquid chromatography assay. Kidney International. 71(1). 74–78. 109 indexed citations
16.
Bloom, Jesse D., Markus Meyer, Peter Meinhold, et al.. (2005). Evolving strategies for enzyme engineering. Current Opinion in Structural Biology. 15(4). 447–452. 284 indexed citations
17.
Langrehr, Jan M., Andreas Kahl, Markus Meyer, et al.. (1997). Prophylactic use of low‐dose urodilatin for prevention of renal impairment following liver transplantation: a randomized placebo‐controlled study. Clinical Transplantation. 11(6). 593–598. 14 indexed citations
18.
Taher, Akmal, Markus Meyer, Christian G. Stief, Udo Jonas, & W. G. Forssmann. (1997). Cyclic nucleotide phosphodiesterase in human cavernous smooth muscle. World Journal of Urology. 15(1). 32–35. 66 indexed citations
19.
Brenner, Paolo, Markus Meyer, Hermann Reichenspurner, et al.. (1995). Significance of prophylactic urodilatin (INN: ularitide) infusion for the prevention of acute renal failure in patients after heart transplantation.. PubMed. 1(3). 137–43. 16 indexed citations
20.
Kirchmaier, C.M., Markus Meyer, P. Spangenberg, et al.. (1990). Platelet membrane defects in fawn hooded bleeder rats. Thrombosis Research. 57(3). 353–360. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chen Chen Breakdown of academic impact, for papers by Fang Liu Breakdown of academic impact, for papers by Yan Chen Breakdown of academic impact, for papers by Matteo Antonio Russo Breakdown of academic impact, for papers by Kenichi Yoshida Breakdown of academic impact, for papers by Mohit Jain Breakdown of academic impact, for papers by Xiaoyan Liu Breakdown of academic impact, for papers by Douglas B. Sawyer Breakdown of academic impact, for papers by Babette B. Weksler Breakdown of academic impact, for papers by Philip A. Marsden
Rankless by CCL
2026